Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: Is psoriasis associated with atherosclerosis?


      Patients with psoriasis may have an increased risk of cardiovascular disease.


      We sought to evaluate the potential association between subclinical atherosclerosis and psoriasis by measuring the intima-media wall thickness (IMT) of the common carotid artery (CCA) in patients with psoriasis and evaluating its correlation with serum leptin and resistin levels.


      The mean IMT (MIMT) of the CCA and leptin, resistin, triglyceride (TG), and total cholesterol levels in serum were determined in 60 patients and 60 healthy sex- and age-matched control subjects.


      Compared with the healthy control subjects, patients with psoriasis had significantly higher MIMT of the CCA and higher levels of serum leptin, resistin, TG, and total cholesterol. In addition, MIMT of the CCA was positively correlated with serum leptin, resistin, TG, and total cholesterol levels in patients with psoriasis.


      This was a cross-sectional single-center study, and we could not evaluate additional biomarkers such as adipokine or adiponectin because of our restricted facilities.


      Although serum leptin, resistin, TG, and total cholesterol levels and MIMT of the CCA were significantly increased in patients with psoriasis, MIMT of the CCA was also positively correlated with these biomarkers. Therefore, psoriasis could be an independent risk factor for subclinical atherosclerosis.

      Key words

      Abbreviations used:

      BMI (body mass index), CCA (common carotid artery), IMT (intima-media wall thickness), MIMT (mean intima-media wall thickness), PASI (Psoriasis Area and Severity Index), TG (triglyceride)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Christophers E.
        Psoriasis–epidemiology and clinical spectrum.
        Clin Exp Dermatol. 2001; 26: 314-320
        • Akhyani M.
        • Ehsani A.H.
        • Robati R.M.
        • Robati A.M.
        The lipid profile in psoriasis: a controlled study.
        J Eur Acad Dermatol Venereol. 2007; 21: 1330-1332
        • Robati R.M.
        • Toossi P.
        • Rahmati-Roodsari M.
        • Khalilazar S.
        • Abolhasani E.
        • Namazi N.
        • et al.
        Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment.
        Sci World J. 2013; 2013: 921819
        • Sommer D.M.
        • Jenisch S.
        • Suchan M.
        • Christophers E.
        • Weichenthal M.
        Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
        Arch Dermatol Res. 2006; 298: 321-328
        • Muoio D.M.
        • Lynis Dohm G.
        Peripheral metabolic actions of leptin.
        Best Pract Res Clin Endocrinol Metab. 2002; 16: 653-666
        • Lord G.M.
        • Matarese G.
        • Howard J.K.
        • Baker R.J.
        • Bloom S.R.
        • Lechler R.I.
        Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.
        Nature. 1998; 394: 897-901
        • Steppan C.M.
        • Bailey S.T.
        • Bhat S.
        • Brown E.J.
        • Banerjee R.R.
        • Wright C.M.
        • et al.
        The hormone resistin links obesity to diabetes.
        Nature. 2001; 409: 307-312
        • Silswal N.
        • Singh A.K.
        • Aruna B.
        • Mukhopadhyay S.
        • Ghosh S.
        • Ehtesham N.Z.
        Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.
        Biochem Biophys Res Commun. 2005; 334: 1092-1101
        • Johnston A.
        • Arnadottir S.
        • Gudjonsson J.E.
        • Aphale A.
        • Sigmarsdottir A.A.
        • Gunnarsson S.I.
        • et al.
        Obesity in psoriasis: leptin and resistin as modulator of cutaneous inflammation.
        Br J Dermatol. 2008; 159: 342-350
        • Mehta N.N.
        • Azfar R.S.
        • Shin D.B.
        • Neimann A.L.
        • Troxel A.B.
        • Gelfand J.M.
        Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.
        Eur Heart J. 2010; 31: 1000-1006
        • Gelfand J.M.
        • Neimann A.L.
        • Shin D.B.
        • Wang X.
        • Margolis D.J.
        • Troxel A.B.
        Risk of myocardial infarction in patients with psoriasis.
        JAMA. 2006; 296: 1735-1741
        • Armstrong E.J.
        • Harskamp C.T.
        • Armstrong A.W.
        Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.
        J Am Heart Assoc. 2013; 2: e000062
        • Mehta N.N.
        • Yu Y.
        • Pinnelas R.
        • Krishnamoorthy P.
        • Shin D.B.
        • Troxel A.B.
        • et al.
        Attributable risk estimate of severe psoriasis on major cardiovascular events.
        Am J Med. 2011; 124: 775.e1-775.e6
        • Gonzalez-Juanatey C.
        • Llorca J.
        • Miranda-Filloy J.A.
        • Amigo-Diaz E.
        • Testa A.
        • Garcia-Porrua C.
        • et al.
        Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors.
        Arthritis Rheum. 2007; 57: 287-293
        • Kimhi O.
        • Caspi D.
        • Bornstein N.M.
        • Maharshak N.
        • Gur A.
        • Arbel Y.
        • et al.
        Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis.
        Semin Arthritis Rheum. 2007; 36: 203-209
        • Craven T.E.
        • Ryu J.E.
        • Espeland M.A.
        • Kahl F.R.
        • McKinney W.M.
        • Toole J.F.
        • et al.
        Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study.
        Circulation. 1990; 82: 1230-1242
        • El-Mongy S.
        • Fathy H.
        • Abdelaziz A.
        • Omran E.
        • George S.
        • Neseem N.
        • et al.
        Subclinical atherosclerosis in patients with chronic psoriasis: a potential association.
        J Eur Acad Dermatol Venereol. 2010; 24: 661-666
        • Enany B.
        • El Zohiery A.K.
        • Elhilaly R.
        • Badr T.
        Carotid intima-media thickness and serum leptin in psoriasis.
        Herz. 2012; 37: 527-533
        • Roman M.J.
        • Shanker B.
        • Davis A.
        • Lockshin M.D.
        • Sammaritano L.
        • Simantov R.
        • et al.
        Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
        N Engl J Med. 2003; 349: 2399-2406
        • Naghavi M.
        • Falk E.
        • Hecht H.S.
        • Jamieson M.J.
        • Kaul S.
        • Berman D.
        • et al.
        From vulnerable plaque to vulnerable patient-part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report.
        Am J Cardiol. 2006; 98: 2H-15H
        • WHO Expert Consultation
        Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
        Lancet. 2004; 363: 157-163
        • Li R.C.
        • Krishnamoorthy P.
        • DerOhannessian S.
        • Doveikis J.
        • Wilcox M.
        • Thomas P.
        • et al.
        Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors.
        Clin Exp Dermatol. 2014; 39: 19-24
        • Boehncke S.
        • Thaci D.
        • Beschmann H.
        • Ludwig R.J.
        • Ackermann H.
        • Badenhoop K.
        • et al.
        Psoriasis patients show signs of insulin resistance.
        Br J Dermatol. 2007; 157: 1249-1251
        • Takahashi H.
        • Tsuji H.
        • Honma M.
        • Ishida-Yamamoto A.
        • Yamamoto A.
        • Iizuka H.
        Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.
        Arch Dermatol Res. 2013; 305: 113-116
        • Kremers H.M.
        • McEvoy M.T.
        • Dann F.J.
        • Gabriel S.E.
        Heart disease in psoriasis.
        J Am Acad Dermatol. 2007; 57: 347-354
        • Jókai H.
        • Szakonyi J.
        • Kontár O.
        • Marschalkó M.
        • Szalai K.
        • Kárpáti S.
        • et al.
        Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study.
        J Am Acad Dermatol. 2013; 69: 523-529